{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:49:39Z","timestamp":1791985779621,"version":"4.4.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/wnf.0b013e3181d4c1f6","type":"journal-article","created":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T14:02:31Z","timestamp":1274796151000},"page":"126-128","source":"Crossref","is-referenced-by-count":15,"title":["Lamotrigine Administration in Panic Disorder With Agoraphobia"],"prefix":"10.1097","volume":"33","author":[{"given":"Vasilios G.","family":"Masdrakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Oulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised.","volume":"157","author":"Gorman","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2165\/00003495-200464190-00004","article-title":"Antiepileptic drugs in the treatment of anxiety disorders: role in therapy.","volume":"64","author":"Van Ameringen","year":"2004","journal-title":"Drugs"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/jcp.0b013e318059361a","article-title":"The role of anticonvulsant drugs in anxiety disorders. A critical review of the evidence.","volume":"27","author":"Mula","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R4-4-20210203","first-page":"134","article-title":"Panic disorder: treatment with valproate.","volume":"55","author":"Woodman","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00004714-200008000-00011","article-title":"Placebo-controlled study of gabapentin treatment of panic disorder.","volume":"20","author":"Pande","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4088\/JCP.v67n1012","article-title":"Safety and efficacy of levetiracetam for patients with panic disorder: results of an open-label, fixed flexible dose study.","volume":"67","author":"Papp","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs.","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"suppl 20","key":"R9-4-20210203","first-page":"22","article-title":"The Mini International Neuropsychiatric Interview (M.I.N.I.). The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1037\/0022-006X.52.6.1090","article-title":"Assessment of fear of fear in agoraphobics: the Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire.","volume":"52","author":"Chambless","year":"1984","journal-title":"J Consult Clin Psychol"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0005-7967(85)90140-8","article-title":"The Mobility Inventory for agoraphobia.","volume":"23","author":"Chambless","year":"1985","journal-title":"Behav Res Ther"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/15622970802465807","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders-first revision.","volume":"9","author":"Bandelow","year":"2008","journal-title":"World J Biol Psychiatry"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.psc.2009.05.005","article-title":"Empirically supported treatments for panic disorder.","volume":"32","author":"McHugh","year":"2009","journal-title":"Psychiatr Clin North Am"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v68n0710","article-title":"Cost-efficacy of individual and combined treatments for panic disorder.","volume":"68","author":"McHugh","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00131746-200407000-00002","article-title":"Cognitive-behavioral treatment for panic disorder: current status.","volume":"10","author":"Landon","year":"2004","journal-title":"J Psychiatr Pract"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/da.1053","article-title":"The prediction of nonresponse to pharmacotherapy in panic disorder: a review.","volume":"14","author":"Slaap","year":"2001","journal-title":"Depress Anxiety"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1461145705005201","article-title":"Evidence-based pharmacotherapy of panic disorder.","volume":"8","author":"Bakker","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/j.1440-1614.2000.0751c.x","article-title":"Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.","volume":"34","author":"Kumar","year":"2000","journal-title":"Aust N Z J Psychiatry"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181d4c1f6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:20:18Z","timestamp":1786040418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201005000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181d4c1f6","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}